AI Article Synopsis

  • PVC is widely used in various materials but degrades under UV light, negatively affecting its properties and lifespan.
  • Four telmisartan organotin(IV) compounds were tested as photostabilizers in PVC films, showing better resistance to degradation compared to unmodified PVC.
  • The organotin(IV) compounds may protect PVC by scavenging harmful radicals and decomposing peroxides, suggesting potential for use as effective PVC additives.

Article Abstract

Poly(vinyl chloride) (PVC), a polymer widely used in common household and industrial materials, undergoes photodegradation upon ultraviolet irradiation, leading to undesirable physicochemical properties and a reduced lifetime. In this study, four telmisartan organotin(IV) compounds were tested as photostabilizers against photodegradation. PVC films (40-µm thickness) containing these compounds (0.5 wt%) were irradiated with ultraviolet light at room temperature for up to 300 h. Changes in various polymeric parameters, including the growth of hydroxyl, carbonyl, and alkene functional groups, weight loss, reduction in molecular weight, and appearance of surface irregularities, were investigated to test the efficiency of the photostabilizers. The changes were more noticeable in the blank PVC film than in the films containing the telmisartan organotin(IV) compounds. These results reflect that these compounds effectively inhibit the photodegradation of PVC, possibly by acting as hydrogen chloride and radical scavengers, peroxide decomposers, and primary photostabilizers. The synthesized organotin(IV) complexes could be used as PVC additives to enhance photostability.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804033PMC
http://dx.doi.org/10.3390/molecules24193557DOI Listing

Publication Analysis

Top Keywords

organotiniv compounds
12
polyvinyl chloride
8
telmisartan organotiniv
8
photodegradation pvc
8
compounds
5
pvc
5
photostabilization polyvinyl
4
organotiniv
4
chloride organotiniv
4
photodegradation
4

Similar Publications

Anticancer behavior of cyclometallated iridium(III)-tributyltin(IV) carboxylate schiff base complexes with aggregation-induced emission.

J Inorg Biochem

January 2025

Key Laboratory of Life-Organic Analysis of Shandong Province, Institute of Anticancer Agents Development and Theranostic Application, School of Chemistry and Chemical Engineering, Qufu Normal University, Qufu 273165, China. Electronic address:

Cyclometallated iridium(III) and organotin(IV) carboxylate complexes have shown potential application value in the field of anticancer. However, the widespread aggregation-caused quenching (ACQ) effect of these complexes is not conducive to the exploration of their targeting and anticancer mechanism, and the idea of aggregation-induced emission (AIE) effect can effectively solve this problem. Then, AIE-activated cyclometallated iridium(III)-tributyltin(IV) carboxylate Schiff base complexes were designed and prepared in this study.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on enhancing photocatalytic activity in carbon nanotubes (CNTs) using organotin(IV) compounds, resulting in hybrid materials (1@CNT and 2@CNT) that generate reactive oxygen species.* -
  • The synthesized compounds were thoroughly characterized using various analytical techniques and showed improved photocatalytic performance compared to bare CNTs due to reduced band gaps and better electron retention.* -
  • Specifically, the hybrid material 1@CNT demonstrated a strong ability to degrade 83% of Amoxicillin under visible light, confirming its effectiveness and stability for environmental remediation over multiple cycles.*
View Article and Find Full Text PDF

Synthesis, structures, and cytotoxicity insights of organotin(IV) complexes with thiazole-appended pincer ligand.

J Inorg Biochem

January 2025

Department of Chemistry, University of Kentucky, 506 Library Drive, 146 Chemistry-Physics Building, Lexington, KY 40506-0055, USA. Electronic address:

Article Synopsis
  • Diorganotin complexes with various compositions were synthesized by reacting organotin oxides with a specific ligand in toluene, and a mono-n-butyltin complex was prepared using acetonitrile.
  • These complexes were characterized through techniques like FT-IR, NMR spectroscopy, and X-ray diffraction, revealing their coordinated structures and forms.
  • The antitumor activities of the first five complexes were tested on T-47D breast cancer cells, with compound 3 showing the highest effectiveness and potential for selective toxicity, positioning it as a promising candidate for breast cancer treatment.
View Article and Find Full Text PDF

Infectious diseases have a significant impact in the historical trajectory of humanity, exerting profound influence on societies, driving advancements in medical science, and significantly impacting individuals on a worldwide scale. Consequently, this research endeavours to identify potent agents combatting tuberculosis, inflammation, and microbial deformities. The investigation focuses on hydrazones (1,2) endowed eight organotin(IV) complexes, where hydrazones were derived from 2-acetyl-1H-indene-1,3(2H)-dione and 2-phenoxypropanehydrazide/2-(2,4-dichlorophenoxy)propanehydrazide.

View Article and Find Full Text PDF

Organotin(IV) complexes derived from 2,6-diacetylpyridine bis(2-hydroxybenzoylhydrazone) as prospective anti-proliferative agents: Synthesis, characterization, structures and in vitro anticancer activity.

J Inorg Biochem

December 2024

Centro de Química Estrutural, Institute of Molecular Sciences, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1049-001 Lisboa, Portugal; Departamento de Engenharia Química, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1049-001 Lisboa, Portugal. Electronic address:

Six organotin(IV) complexes, viz., [MeSn(L)] (1), [n-BuSn(L)] (2), [n-OctSn(L)] (3), [BzSn(L)]·0.5CH (4), [n-BuSn(L)Cl] (5), and [PhSn(L)Cl] (6), were synthesized using a 2,6-diacetylpyridine bis(2-hydroxybenzoylhydrazone), HL.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!